Filter
6967
Filtered Results: 6967
Text search:
Medicine
Management
Featured
Recommendations
692
New Publications
1805
Language
Document type
No document type
3767
Studies & Reports
1199
Guidelines
1041
Manuals
393
Strategic & Response Plan
253
Training Material
116
Fact sheets
101
Situation Updates
57
Resource Platforms
14
Online Courses
9
Brochures
7
Infographics
7
App
2
Videos
1
Countries / Regions
India
319
Global
267
Kenya
194
South Africa
168
Ethiopia
143
Nepal
131
Uganda
131
Sierra Leone
129
Western and Central Europe
129
Nigeria
126
Liberia
121
Latin America and the Carribbean
113
Africa
104
Tanzania
102
Bangladesh
99
Malawi
97
Zambia
92
Myanmar / Burma
89
Ghana
83
Rwanda
82
Ukraine
77
Syria
75
Congo, Democratic Republic of
64
Eastern Europe
60
Philippines
59
Namibia
53
Mozambique
49
Brazil
48
South–East Asia Region
46
Zimbabwe
41
Indonesia
41
Guinea
39
Russia
38
Asia
35
Lesotho
34
South Sudan
33
Senegal
32
West and Central Africa
30
Burkina Faso
29
Haiti
29
Cambodia
29
Germany
28
Colombia
27
East and Southern Africa
26
Middle East and North Africa
24
Botswana
24
Cameroon
23
Venezuela
23
Yemen
23
Eswatini/ Swaziland
20
Eastern Europe and Central Asia
17
Chile
16
Afghanistan
16
USA
16
Benin
15
Pakistan
15
Ecuador
14
Madagascar
14
Thailand
13
Sudan
13
Peru
12
Western Pacific Region
12
Lebanon
12
Moldova
12
Tajikistan
11
Paraguay
11
Argentina
11
Mali
11
Jordan
10
North America
10
Bolivia
10
Vietnam
10
China
9
Spain
9
Somalia
9
El Salvador
8
Laos
8
Sri Lanka
8
Central African Republic
8
Angola
8
Iraq
8
Mexico
7
Albania
7
Côte d’Ivoire / Ivory Coast
7
Georgia
7
North Macedonia
6
Turkey
6
Iran
6
Southern Africa
6
Palestine
6
United Kingdom
5
Kazakhstan
4
Kyrgyzstan
4
Niger
4
Burundi
4
Guinea-Bissau
4
France
4
Papua New Guinea
4
Egypt
4
Poland
4
Chad
4
Libya
4
Bhutan
4
Timor Leste/ East Timor
3
Gambia
3
Togo
3
Canada
3
Fiji
3
Estonia
3
Uzbekistan
3
Armenia
3
Hungary
3
Saudi Arabia
3
Jamaica
3
Mauritius
3
Portugal
3
Romania
3
Serbia
2
Qatar
2
Bulgaria
2
Italy
2
Lithuania
2
Turkmenistan
2
Japan
2
Belarus
2
Nicaragua
2
Greece
2
Honduras
2
Australia
1
Singapore
1
Congo-Brazzaville
1
Morocco
1
Mauritania
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Djibouti
1
Slovakia
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2639
Clinical Guidelines
639
Public Health
428
Women & Child Health
319
Key Resources
310
Capacity Building
135
Pharmacy & Technologies
82
Annual Report MEDBOX
3
Toolboxes
COVID-19
566
Mental Health
559
HIV
478
TB
444
AMR
297
NTDs
243
Caregiver
233
Pharmacy
214
NCDs
191
Ebola & Marburg
188
Rapid Response
186
Disability
184
Planetary Health
182
Conflict
161
Global Health Education
102
Refugee
81
Natural Hazards
78
Health Financing Toolbox
66
Specific Hazards
40
Zika
37
Cholera
27
Social Ethics
24
Polio
18
Malaria
11
Typhoon
1
For 50 SAM children with medical complications and for a paediatric ward of 10-15 beds for 3 months
The PED/SAM kit is especially designed to provide medicines, renewables and equipment suitable for children and to treat the common childhood illness including severe acute malnutrition with medica...
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme...
The Transatlantic Task Force on Antimicrobial Resistance (TATFAR) fosters cooperation between the European Union (EU) andthe United States (US) on the issue of antimicrobial resistance. The first TATFAR recommendation refers to appropriate use of antimicrobials in human medicine through hospital Ant...
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Ethiopia GATS was implemented by Ethiopia Public Health Institute (EPHI) in collaboration with the Ethiopian Food, Medicine, Health Care Administration and Control Authority (FMHACA), CSA, FMOH and the World Health Organization (WHO)country office. Technical assistance ...
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis a...
This is the first edition of Empiric Antibiotic Guidelines, as a guidance to all medical practitioners at North Okklapa General & Teaching Hospital.
Antibiotics are critical in the management of infection and can have a significant impact in reducing morbidity and mortality. Emerging antimicrobia...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that...
The full-scale invasion of Ukraine has caused a deterioration in the level of access to health-care services and medicines in the country, particularly for people living in regions close to the front line and areas that are not partially or fully controlled by the Government of Ukraine, and for peop...
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interventions within their context, closing the gaps in ca...
DOI:https://doi.org/10.1016/S2213-2600(20)30316-7
The Lancet Respiratory Medicine
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
This action plan for the Kingdom Saudi Arabia to combat antimicrobial resistance has been formulated in the line of the WHO five objectives. It addresses the need for effective “one health” approach involving coordination among numerous national sectors and actors, including human and veterinary...
The Ideal Clinic Realisation and Maintenance (ICRM) programme was initiated by the National Department of Health in July 2013 in order to systematically improve primary health care (PHC) facilities and the quality of care they provide. The Ideal Clinic framework/dashboard sets out the standards for ...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
